Sponsor

University of Birmingham

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Birmingham appears in 64 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials64
Recruiting shown14
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer TreatmentNCT07160686 · lead sponsor · 2026-04-28
RECRUITING
Effects of Obesity on Autophagy and mTORC1 Signalling in Skeletal MuscleNCT07774676 · lead sponsor · 2026-04-15
RECRUITING
GLycaemic Outcomes With Whey Protein in ageINGNCT07285811 · lead sponsor · 2026-01-02
RECRUITING
IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost EffectivenessNCT07440277 · lead sponsor · 2023-07-18
RECRUITING
Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for HypertensionNCT07294794 · lead sponsor · 2026-01-19
NOT_YET_RECRUITING
Sputum Colour Charts to Guide Antibiotic Self-treatment of Acute Exacerbation of COPD (Colour COPD)NCT04705233 · lead sponsor · 2021-12-14
UNKNOWN
Predict&Prevent: Use of a Personalised Early Warning Decision Support System to Predict and Prevent Acute Exacerbations of COPDNCT04136418 · lead sponsor · 2020-10-07
UNKNOWN
Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic CrisisNCT04384926 · lead sponsor · 2020-03-30
UNKNOWN
NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast CancerNCT04118192 · lead sponsor · 2019-05-22
ACTIVE_NOT_RECRUITING
Effect of mCPP on Cognitive Control, Appetite, and Neural ResponsesNCT03962829 · lead sponsor · 2019-02-01
TERMINATED
Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort StudyNCT04734496 · lead sponsor · 2019-01-01
UNKNOWN
Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram SyndromeNCT03717909 · lead sponsor · 2018-12-28
COMPLETED
Effect of Intranasal Insulin on Cognitive Processes and AppetiteNCT03632681 · lead sponsor · 2018-04-23
COMPLETED
Obstructive Sleep Apnoea in Patients With Type 1 DiabetesNCT03481361 · lead sponsor · 2018-02-14
COMPLETED
Concurrent Training in Type 2 DiabetesNCT03278704 · lead sponsor · 2017-12-06
TERMINATED
Exercise-meal Timing and Postprandial Glucose ControlNCT03730727 · lead sponsor · 2017-10-09
COMPLETED
Hyperglycemia and Exercise.NCT03284216 · lead sponsor · 2017-08-01
COMPLETED
Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2NCT02733159 · lead sponsor · 2017-01-04
COMPLETED
Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson'sNCT02561715 · lead sponsor · 2015-08-01
WITHDRAWN
Obesity-related Inflammation in Patients Prior to and After Bariatric SurgeryNCT03283644 · lead sponsor · 2015-06-01
COMPLETED
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerNCT02664935 · lead sponsor · 2015-05-13
COMPLETED
Nutrition, Exercise and Muscle Metabolism in ObesityNCT02397304 · lead sponsor · 2015-04-01
UNKNOWN
Mechanisms of Age-Related Muscle LossNCT03113279 · lead sponsor · 2014-08-01
COMPLETED
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.NCT02017444 · lead sponsor · 2014-04-25
COMPLETED
An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIHNCT02124486 · lead sponsor · 2014-03-06
UNKNOWN
A Clinical Trial of AdNRGM Plus CB1954 in Prostate CancerNCT04374240 · lead sponsor · 2013-03-19
COMPLETED
Ambulatory Oxygen Effects on Muscles in COPDNCT01722370 · lead sponsor · 2012-08-01
COMPLETED
Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid ArthritisNCT02441920 · lead sponsor · 2010-11-01
TERMINATED
Liraglutide Efficacy and Action in Non-Alcoholic SteatohepatitisNCT01237119 · lead sponsor · 2010-08-01
COMPLETED
Epidemiology of Complications After Solid Organ Transplantation - EpCOT StudyNCT02991105 · lead sponsor · 1985-01-01
ACTIVE_NOT_RECRUITING
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.NCT07440290 · collaborator · 2026-04-01
RECRUITING
Benefits of Retained Insulin for Good HealthNCT07828626 · collaborator · 2025-10-31
RECRUITING
UK Islet Autoantibody RegistryNCT07125365 · collaborator · 2025-07-11
RECRUITING
Preparatory Work for a Trial of Adjuncts to Diuretic Treatment in Patients Hospitalised With Heart Failure: Addressing Uncertainties and Building ConsensusNCT07281040 · collaborator · 2025-07-02
RECRUITING
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsNCT05786716 · collaborator · 2023-03-07
RECRUITING
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.NCT05768178 · collaborator · 2023-03-01
RECRUITING
Understanding Motivation in Parkinson's Patients Through NeurophysiologyNCT05065151 · collaborator · 2021-10-30
RECRUITING
Maternal Grandmothers in the Born in Guangzhou Cohort StudyNCT03633162 · collaborator · 2018-05-21
RECRUITING
The European NAFLD RegistryNCT04442334 · collaborator · 2015-05-01
RECRUITING
The Born in Guangzhou Cohort Study (BIGCS)NCT02526901 · collaborator · 2012-02-01
RECRUITING
Building Healthy Food Environment in Schools: Evaluating Co-created Interventions in Low Resource Settings. #BetterNutrition4AdolescentNCT07332676 · collaborator · 2026-10-01
NOT_YET_RECRUITING
Mental Health Mission Mood Disorder Cohort StudyNCT07189689 · collaborator · 2025-10-01
NOT_YET_RECRUITING
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )NCT05221229 · collaborator · 2022-04-17
ACTIVE_NOT_RECRUITING
Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery PlatformNCT04777006 · collaborator · 2021-09-01
COMPLETED
Head and Neck cancERs International cOviD-19 collabOraTionNCT04632173 · collaborator · 2021-05-03
UNKNOWN
English Mammography Screening Outcomes by Age, Frequency and Test ThresholdNCT05247463 · collaborator · 2021-01-01
UNKNOWN
3mg Liraglutide for Overweight or ObesityNCT03885297 · collaborator · 2019-01-18
COMPLETED
HIT on Hypoglycaemic Risk in T1DNCT05044442 · collaborator · 2018-10-01
COMPLETED
HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)NCT03598400 · collaborator · 2018-08-01
COMPLETED
The BLF Early COPD Development Partnership GrantNCT03480347 · collaborator · 2018-01-17
UNKNOWN
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of HypertensionNCT03334149 · collaborator · 2017-11-22
COMPLETED
Attentive Eating for Weight LossNCT03602001 · collaborator · 2017-09-07
COMPLETED
The Effect of Very Low Calorie Diet With and Without Exercise on Muscle Synthesis in Middle-aged Overweight Male.NCT03116256 · collaborator · 2017-01-09
UNKNOWN
A Study Into Airways Disease Case Finding and ManagementNCT03355677 · collaborator · 2017-01-01
COMPLETED
Parents Resources for Decreasing the Incidence of Change Triggered Temper OutburstsNCT02567357 · collaborator · 2015-01-01
COMPLETED
Lifestyle Modifications for the Treatment of Sarcopenic ObesityNCT02379026 · collaborator · 2014-10-01
UNKNOWN
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and MechanismsNCT02928965 · collaborator · 2013-02-01
COMPLETED
Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's DiseaseNCT01014858 · collaborator · 2013-01-01
TERMINATED
A Study of Selumetinib in Patients With Kaposi's SarcomaNCT01752569 · collaborator · 2012-06-15
TERMINATED
Gastric Bypass, Gastric Band or Sleeve Gastrectomy to Treat ObesityNCT02841527 · collaborator · 2012-01-01
COMPLETED

Drugs studied in this sponsor's trials

22 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Birmingham as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
selumetinib2
amiloride1
apixaban1
cobimetinib1
crizotinib1
dabrafenib1
docetaxel1
donepezil1
selumetinib RxCUI 2289380 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials amiloride RxCUI 644 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial apixaban RxCUI 1364430 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial cobimetinib RxCUI 1722365 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial crizotinib RxCUI 1148495 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dabrafenib RxCUI 1424911 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial donepezil RxCUI 135447 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial durvalumab RxCUI 1919503 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial liraglutide RxCUI 475968 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial minocycline RxCUI 6980 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial osimertinib RxCUI 1721560 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial oxygen RxCUI 7806 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial palbociclib RxCUI 1601374 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pembrolizumab RxCUI 1547545 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pertuzumab RxCUI 1298944 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial placebo Oral Tablet RxCUI 375221 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Saxenda RxCUI 1598264 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial trametinib RxCUI 1425099 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial trastuzumab RxCUI 224905 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial vemurafenib RxCUI 1147220 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

collaborator34
lead sponsor30
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.